Table of Contents Table of Contents
Previous Page  52 / 60 Next Page
Information
Show Menu
Previous Page 52 / 60 Next Page
Page Background

50

NCCN Guidelines for Patients

®

:

Breast Cancer – Metastatic (STAGE IV), Version 2.2017

tumor markers

Proteins in the blood that are measured to assess if cancer

treatment is working.

vascular endothelial growth factor (VEGF)

A molecule that binds to cells that form blood vessels.

Acronyms

AJCC

American Joint Committee on Cancer

CA

cancer antigen

CBC

complete blood count

CDK

cyclin-dependent kinase

CEA

carcinoembryonic antigen

CT

computed tomography

DNA

deoxyribonucleic acid

ECOG

Eastern Cooperative Oncology Group

FDA

Food and Drug Administration

FDG

fluorodeoxyglucose

FSH

follicle-stimulating hormone

HER2

human epidermal growth factor receptor 2

IHC

immunohistochemistry

ISH

in situ hybridization

LHRH

luteinizing hormone-releasing hormone

KPS

Karnofsky Performance Status

mTOR

mammalian target of rapamycin

NCCN®

National Comprehensive Cancer Network

®

MRI

magnetic resonance imaging

PET

positron emission tomography

PET/CT

positron emission tomography/ computed tomography

SERD

selective estrogen receptor degrader

SERM

selective estrogen receptor modulator

VEGF

vascular endothelial growth factor

VUS

variants of unknown significance

Acronyms